Rock Creek Pharmaceuticals, Inc. Report issue

For profit Phase 1 Phase 2
Founded: Sarasota FL United States (1985)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2010
NCT01262170
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Star Scientific, Inc

Active Ingredients

Drugs in Phase 2 Trials (1)

anatabine (4 trials)

Drugs in Phase 1 Trials (1)

caffeine (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Thyroiditis (Phase 2)

Thyroiditis, Autoimmune (Phase 2)

Tobacco Use Disorder (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 2